Back to search results

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

Abroad (travel likely)Recruiting

Conditions

Metastatic Castration Resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Novartis Investigative Site, Konstanz, Baden-Wurttemberg, Germany

  • Novartis Investigative Site, Stuttgart, Baden-Wurttemberg, Germany

  • Novartis Investigative Site, Munich, Bavaria, Germany

  • Novartis Investigative Site, Regensburg, Bavaria, Germany

  • Novartis Investigative Site, Würzburg, Bavaria, Germany

  • Novartis Investigative Site, Cottbus, Brandenburg, Germany

  • Novartis Investigative Site, Frankfurt (Oder), Brandenburg, Germany

  • Novartis Investigative Site, Ludwigshafen, Germany, Germany

  • Novartis Investigative Site, Marburg, Hesse, Germany

  • Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany

  • Novartis Investigative Site, Dresden, Saxony, Germany

  • Novartis Investigative Site, Leipzig, Saxony, Germany

  • Novartis Investigative Site, Halle, Saxony-Anhalt, Germany

  • Novartis Investigative Site, Jena, Thuringia, Germany

  • Novartis Investigative Site, Aachen, Germany

  • Novartis Investigative Site, Augsburg, Germany

  • Novartis Investigative Site, Berlin, Germany

  • Novartis Investigative Site, Berlin, Germany

  • Novartis Investigative Site, Berlin, Germany

  • Novartis Investigative Site, Bielefeld, Germany

  • Novartis Investigative Site, Bonn, Germany

  • Novartis Investigative Site, Braunschweig, Germany

  • Novartis Investigative Site, Chemnitz, Germany

  • Novartis Investigative Site, Dortmund, Germany

  • Novartis Investigative Site, Dortmund, Germany

  • Novartis Investigative Site, Erfurt, Germany

  • Novartis Investigative Site, Erlangen, Germany

  • Novartis Investigative Site, Essen, Germany

  • Novartis Investigative Site, Fulda, Germany

  • Novartis Investigative Site, Herford, Germany

  • Novartis Investigative Site, Homburg, Germany

  • Novartis Investigative Site, Magdeburg, Germany

  • Novartis Investigative Site, Mainz, Germany

  • Novartis Investigative Site, Nuremberg, Germany

  • Novartis Investigative Site, Rostock, Germany

  • Novartis Investigative Site, Trier, Germany

  • Novartis Investigative Site, Tübingen, Germany

  • Novartis Investigative Site, Ulm, Germany

Study leads

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

View source on ClinicalTrials.gov(opens in a new tab)